MedPath

se of continuous glucose monitoring devices among people living with type 1 diabetes in Kenya.

Not Applicable
Conditions
Nutritional, Metabolic, Endocrine
Registration Number
PACTR202309743823347
Lead Sponsor
Foundation for Innovative New Diagnostics
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
246
Inclusion Criteria

Recipient of care participants are eligible to be included in the Study only if all the following inclusion criteria apply:
•People living with T1 diabetes with HbA1c levels =10% (with at least 1 measurement over 18 months prior to study enrolment) who are attending for diabetes care at the 3 study clinics.

Care givers to children/adolescents living with T1 diabetes are eligible to be included in the study only if all the following inclusion criteria apply:
•The child/adolescent that the person is a care giver to is enrolled in the study.

Healthcare providers are eligible to be included in the study only if all the following inclusion criteria apply:
•Healthcare provider at the study sties engaged in diabetes care provision related to the study.

Exclusion Criteria

•People living with type 1 diabetes under 4 years of age.
•People diagnosed with Type 1 diabetes within the last 2 years.
•People who have used a CGM in the last 18 months prior to enrollment
•People living with type 2 diabetes.
•Known pregnancy at the time of study enrolment.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath